ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The path forward for the use of neonicotinoid insecticides in Europe grew foggy last week after the European Food Safety Authority (EFSA) released an updated assessment concluding that use of the chemicals carries high risk to honeybees, wild bees, and bumblebees. EFSA based its assessment on scientific evidence gathered since 2013. That year, the European Union restricted the use of three neonicotinoids—clothianidin, imidacloprid, and thiamethoxam—on the basis of research available at the time. The ban was originally set to expire after two years, but in 2015 additional studies were released that continued to show risks to bee health. At the time, Bayer Cropscience, maker of clothianidin and imidacloprid, and Syngenta, maker of thiamethoxam, said the restrictions were based on a flawed assessment and that the research was incomplete. In response to the new report, Bayer contends the pesticides can be used without harming bees. The company criticizes the guidance EFSA developed to measure risk to pollinators as “unworkable.”
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter